It is known that ERα cistrome is reprogrammable and TNFα has been shown to reshape the genomic action of estrogen in breast cancer cells through redistribution of NF-kB and pioneer factor FOXA1 binding across the genome (Frasor et al., 2009; Franco et al., 2015). Here, NFKB1 is linked to breast carcinoma.